Effect of Food Intake and Body Position on the Pharmacokinetics of Swallowed APT‐1011, a Fluticasone Orally Disintegrating Tablet, in Healthy Adult Volunteers-Reference-Cited by-同舟云学术

Effect of Food Intake and Body Position on the Pharmacokinetics of Swallowed APT‐1011, a Fluticasone Orally Disintegrating Tablet, in Healthy Adult Volunteers

Published:2020-01-15 Issue:6 Volume:60 Page:734-743
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Comer Gail M.¹,Bush Mark A.²,Dellon Evan S.³,Marino Mark T.⁴^ORCID

Affiliation:

1. Adare Pharmaceuticals Lawrence Township New Jersey USA

2. Nuventra Pharma Sciences Durham North Carolina USA

3. Center for Esophageal Diseases and SwallowingDivision of Gastroenterology and HepatologyUniversity of North Carolina School of Medicine Chapel Hill North Carolina USA

4. Mark T. Marino, Consulting, LLC Carlsbad California USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1572

Reference24 articles.

1. ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)

2. Health-Care Utilization, Costs, and the Burden of Disease Related to Eosinophilic Esophagitis in the United States

3. Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference

4. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Budesonide Oral Suspension in Healthy Adult Participants: A Randomized Phase 1 Study;The Journal of Clinical Pharmacology;2024-09-12

2. Eosinophilic esophagitis: Current concepts in diagnosis and management;Saudi Journal of Gastroenterology;2024-05-16

3. Novel corticosteroid formulations in the treatment of eosinophilic esophagitis: what is the evidence?;Acta Gastro Enterologica Belgica;2023-09

4. Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial;Clinical Gastroenterology and Hepatology;2022-11

5. Formulations of Topical Steroids in Eosinophilic Esophagitis—Current Treatment and Emerging Possibilities;Journal of Clinical Medicine;2022-03-07